Spectrofluorometric Determination of Certain Antihyperlipidemic Agents in Bulk and Pharmaceutical Preparations

about

Spectrofluorometric Determination of Certain Antihyperlipidemic Agents in Bulk and Pharmaceutical Preparations

Item

http://www.wikidata.org/entity/Q58911235

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2012

@uk

name

Spectrofluorometric Determinat ...... nd Pharmaceutical Preparations

@en

Spectrofluorometric Determinat ...... nd Pharmaceutical Preparations

@nl

type

Item

label

Spectrofluorometric Determinat ...... nd Pharmaceutical Preparations

@en

Spectrofluorometric Determinat ...... nd Pharmaceutical Preparations

@nl

prefLabel

Spectrofluorometric Determinat ...... nd Pharmaceutical Preparations

@en

Spectrofluorometric Determinat ...... nd Pharmaceutical Preparations

@nl

P1476

Spectrofluorometric Determinat ...... nd Pharmaceutical Preparations

@en

P2093

Ahmed M. Kadry

http://www.w3.org/2001/XMLSchema#string

Ehab F. ElKady

http://www.w3.org/2001/XMLSchema#string

Ramzia I. El-Bagary

http://www.w3.org/2001/XMLSchema#string

P2860

Determination of rosuvastatin in rat plasma by HPLC: Validation and its application to pharmacokinetic studies.

Simultaneous quantitation of rosuvastatin and gemfibrozil in human plasma by high-performance liquid chromatography and its application to a pharmacokinetic study.

Determination of two HMG-CoA reductase inhibitors, pravastatin and pitavastatin, in plasma samples using liquid chromatography-tandem mass spectrometry for pharmaceutical study.

Fluorimetric determination of some thioxanthene derivatives in dosage forms and biological fluids.

Development and validation of a reversed-phase HPLC method for the determination of ezetimibe in pharmaceutical dosage forms.

Solid-phase extraction and liquid chromatography/tandem mass spectrometry assay for the determination of pitavastatin in human plasma and urine for application to Phase I clinical pharmacokinetic studies.

Application of first-derivative, ratio derivative spectrophotometry, TLC-densitometry and spectrofluorimetry for the simultaneous determination of telmisartan and hydrochlorothiazide in pharmaceutical dosage forms and plasma.

Development and validation of a liquid chromatography-tandem mass spectrometric assay for pitavastatin and its lactone in human plasma and urine.

Liquid chromatography-negative ion electrospray tandem mass spectrometry method for the quantification of ezetimibe in human plasma.

A LC-MS/MS method to quantify the novel cholesterol lowering drug ezetimibe in human serum, urine and feces in healthy subjects genotyped for SLCO1B1.

P304

83-92

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2012/913913

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime